Trails Edge Capital Partners, LP

SEC CIK: 0002077247
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

IMVT holding history

Immunovant, Inc. in every 13F filed by Trails Edge Capital Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IMVT overview All 13F holders of IMVT Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2025

Holdings of IMVT by Trails Edge Capital Partners, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−414,054−100.0%	Sold out	Holders
Q1 2026	414,054	$10.3M	2.4%	+173,889+72.4%	Added	Holders
Q4 2025	240,165	$6.10M	1.5%	–	No prior filing	Holders